Mayo Clinic Platform Overview
Mayo Clinic Investment arm
Latest News
growth-positive
The bioprinted skin model is designed to serve as an alternative to animal testing for preclinical research. According to a scientific article published in the...
CollPlant Biotechnologies, in collaboration with Mayo Clinic, has developed a fully humanized 3D bioprinted skin model using its plant-derived recombinant human collagen (rhCollagen). This innovative model serves as an alternative to animal testing for preclinical research and has potential applications in cosmetic and pharmaceutical testing, disease modeling, and drug development. The collaboration highlights the advantages of using rhCollagen-based bioinks for high-throughput production of personalized human skin models, which could significantly impact regenerative medicine. CollPlants partnership with Mayo Clinic and its existing agreement with Allergan for dermal and soft tissue fillers further solidify its position in the regenerative and aesthetic medicine market.
Partners
Team Members
0
Web & Social Links
Photos & Videos
No files yet
Mayo Clinic Platform Business
Business models
—
Product stage
—
Employees
—
Sector
—Target Customer
—Core Technology
—Mayo Clinic Platform Financials
—
Total funding
—
Capital raised
—
Last funding
—
Funding stage
—
Total rounds
—
Investors
Mayo Clinic Platform Lifecycle
Mayo Clinic Platform News
1 article
growth-positive
The bioprinted skin model is designed to serve as an alternative to animal testing for preclinical research. According to a scientific article published in the...
CollPlant Biotechnologies, in collaboration with Mayo Clinic, has developed a fully humanized 3D bioprinted skin model using its plant-derived recombinant human collagen (rhCollagen). This innovative model serves as an alternative to animal testing for preclinical research and has potential applications in cosmetic and pharmaceutical testing, disease modeling, and drug development. The collaboration highlights the advantages of using rhCollagen-based bioinks for high-throughput production of personalized human skin models, which could significantly impact regenerative medicine. CollPlants partnership with Mayo Clinic and its existing agreement with Allergan for dermal and soft tissue fillers further solidify its position in the regenerative and aesthetic medicine market.
Partners
Mayo Clinic Platform Team
No team members listed.
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
Mayo Clinic Platform Internal
Recent Updates
Yanina Wainscheinker
· yanina.wainscheinker@sncentral.org · Manual · 2023-04-10 13:22:37.000000
Ortal Wein
· ortalw@sncentral.org · Automatic · 2025-10-29 09:00:21.000000
Yanina Wainscheinker
· yanina.wainscheinker@sncentral.org · Manual · 2023-04-10 13:22:37.000000
Yanina Wainscheinker
· yanina.wainscheinker@sncentral.org · Manual · 2023-04-10 13:22:37.000000
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 8/100 |
| Missing | funding stage, product stage, sector, founding year, founding month, number of employees, tags, invite member, business model, address, description, homepage, video or image, funding rounds, news, markets, external profiles, not claimed |
| Creator | Yanina Wainscheinker |
| Creator email | yanina.wainscheinker@sncentral.org |
| Last update | 2023-04-10T00:00:00.000Z |
| Created | 2023-04-10T00:00:00.000Z |